Paychex beat earnings estimates for the fourth straight quarter, then watched its stock crater anyway as investors zeroed in on a single line item that raised uncomfortable questions about what it actually costs to…
Palantir just posted its ninth consecutive earnings beat and revenue growth that left Wall Street scrambling to revise its models upward, yet the stock still sits 9% below its peak. Whether that gap is…
Exelon's dividend yield has climbed to its most attractive level in years, but a single regulatory decision this December could determine whether that income stream grows, stalls, or forces a flood of new stock…
Starship reaching orbit scrambles the economics for every rocket startup, and Rocket Lab and Redwire are betting on opposite strategies to survive the fallout. Only one of those bets looks smart right now.
Google builds its own AI chips, runs its own cloud, and controls its own models, yet still hands billions to NVIDIA every quarter. That uneasy relationship is starting to shift in ways that may…
Zcash turned in the most explosive crypto rally of 2026, then North Korean hackers started funneling stolen funds through its privacy shield. Now investors face a question that goes beyond profit-taking: does the very…
AppLovin's stock has cratered while its underlying business posts explosive revenue growth and billion-dollar profits, a contradiction that has Wall Street's sharpest minds drawing radically different conclusions about where this AI ad-tech giant goes…
Altria's 6.6% yield and 60 consecutive raises look bulletproof until you dig into what sits beneath them: a shrinking core business, a failed smoke-free pivot, and a balance sheet with liabilities that dwarf its…
Goldman Sachs just overhauled its Conviction List with five new additions, and the upside targets on some of these picks will raise eyebrows. One hyperscaler alone carries a 51% potential gain, but it is…
Broadcom just agreed to loan a customer tens of billions of dollars to buy Broadcom's own chips, putting the company on both sides of the deal at once. Whether that circles cash into guaranteed…
Broadcom's biggest headlines drew the biggest crowds, but buying on those moments produced wildly different outcomes depending on which milestone you picked. One entry turned $1,000 into a fortune, another turned it into a…
The 2027 COLA announcement lands in October, but the number Social Security publishes and the number that hits your bank account are two very different figures, and Medicare is the reason why.
A Ripple-backed company with nearly half a billion XRP tokens is about to land on Nasdaq, yet the token price has barely flinched. Understanding why reveals something surprising about who actually benefits when a…
Fifty-two analysts cover Microsoft and not one recommends selling, yet the stock has gone nowhere for a year while Azure just crossed a historic revenue threshold. Something in that gap between Wall Street conviction…
Stocks clawed back from a wild Thursday session, oil surged past $100, and Wall Street analysts reshuffled their bets on names from Airbnb to Northrop Grumman. Find out which stocks got upgraded, downgraded, or…
